| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.08 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.09 |